US regulators approve Takeda’s Orzeyful for narcolepsy
US regulators approved Takeda’s Orzeyful (oveporexton), an orexin agonist, for narcolepsy in August 2026. The drug has since received approval in three countries, although the countries are not identified in the supplied report. The approval targets the…
